| Absorption |
| Blood-Brain Barrier | BBB- | 0.7988 |
| Human Intestinal Absorption | HIA+ | 0.9935 |
| Caco-2 Permeability | Caco2+ | 0.7576 |
| P-glycoprotein Substrate | Non-substrate | 0.7539 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9911 |
| Non-inhibitor | 0.9909 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9053 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5590 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7394 |
| CYP450 2D6 Substrate | Non-substrate | 0.6413 |
| CYP450 3A4 Substrate | Non-substrate | 0.5865 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5281 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8797 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8213 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6666 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7757 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9088 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8851 |
| Non-inhibitor | 0.9350 |
| AMES Toxicity | Non AMES toxic | 0.7841 |
| Carcinogens | Non-carcinogens | 0.7991 |
| Fish Toxicity | High FHMT | 0.5082 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9863 |
| Honey Bee Toxicity | High HBT | 0.5880 |
| Biodegradation | Not ready biodegradable | 0.9078 |
| Acute Oral Toxicity | III | 0.6119 |
| Carcinogenicity (Three-class) | Non-required | 0.6960 |